Is It Worth Investing In Galena Biopharma Inc(NASDAQ:GALE), Sequenom, Inc.(NASDAQ:SQNM), and Tullow Oil Plc(UK)(OTCMKTS:TUWOY)?
New York, NY – GDP INSIDER – 12/18/2014.
This investment analysis article discusses Galena Biopharma Inc(NASDAQ:GALE), Sequenom, Inc.(NASDAQ:SQNM), and Tullow Oil Plc(UK)(OTCMKTS:TUWOY)
Galena Biopharma Inc(NASDAQ:GALE) announced on December 11 that the preliminary immunohistochemistry (IHC) screening data from the NeuVax(TM) (nelipepimut-S) Phase 3 PRESENT trial had been disclosed at the 2014 San Antonio Breast Cancer Symposium. The company has carried out laboratory testing for potential patients to ensure that the targeted patient population is included in the testing. The stock price of the company over the past 52 weeks has been traded within the range of $1.51 and $7.77, while the stock closed yesterday at $1.63 with 6.54% gain of $0.10.
Sequenom, Inc.(NASDAQ:SQNM) moved up 2.33% to $3.52 with a gain of $0.08. The 52 week range for the stock price is $2.02 and $4.19. Sequenom enjoys a fairly positive analyst ratings with the average rating inclined towards “buy”. Following the end of a long standing patent dispute with Illumina, the company’s stock has regained strength as Illumina will pay royalty to Sequenom through 2020 resulting in a rise in Sequenom’s revenue. The market capital of the company remained at $407.2 million.
Tullow Oil Plc(UK)(OTCMKTS:TUWOY) closed yesterday at $3.05 with a 4.63% gain of $0.13. Although the current share price is close to the low end of 52 week range, the stock has an average ‘buy’ rating with a price target estimate of $12.03. It can be said that the overall slump in oil prices is hugely responsible for the recent decline in Tullow’s stock price. However, considering the positive ratings for the stock, the price is expected to rebound soon.
HotStockGains.com provides investors and traders with trading strategies via text message and email. To obtain text message stock alerts service text the word BREAKOUT to 555888 from your cell phone.
Additionally, HotStockGains free newsletter provides market insight, tips, and trading strategies on NYSE, NASDAQ, OTCBB and PINK stocks.
Disclosure: HotStockGains is not a registered investment adviser and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Always seek help from a professional financial advisor (I am not one). Please visit http://hotstockgains.com/disclaimer/ for complete risks and disclosures.